Witnessing the stock’s movement on the chart, on February 11, 2021, TransMedics Group Inc. (NASDAQ: TMDX) had a quiet start as it plunged -0.23% to $29.95. During the day, the stock rose to $34.4999 and sunk to $29.3907 before settling in for the price of $30.02 at the close. Taking a more long-term approach, TMDX posted a 52-week range of $10.10-$35.70.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -101.20%. This publicly-traded company’s shares outstanding now amounts to $27.16 million, simultaneously with a float of $23.83 million. The organization now has a market capitalization sitting at $817.04 million. At the time of writing, stock’s 50-day Moving Average stood at $20.01, while the 200-day Moving Average is $16.83.
While finding the extent of efficiency of the company that is accounted for 109 employees. It has generated 216,550 per worker during the last fiscal year. Meanwhile, its income per employee was -307,771. The stock had 4.72 Receivables turnover and 0.32 Total Asset turnover. For the Profitability, stocks gross margin was +57.79, operating margin was -125.42 and Pretax Margin of -141.95.
TransMedics Group Inc. (TMDX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. TransMedics Group Inc.’s current insider ownership accounts for 1.40%, in contrast to 78.40% institutional ownership. According to the most recent insider trade that took place on Feb 09, this organization’s Director sold 10,168 shares at the rate of 32.83, making the entire transaction reach 333,786 in total value, affecting insider ownership by 424,637. Preceding that transaction, on Feb 09, Company’s 10% Owner sold 786,664 for 33.32, making the whole transaction’s value amount to 26,208,734. This particular insider is now the holder of 2,624,712 in total.
TransMedics Group Inc. (TMDX) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.19 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.32) by $0.13. This company achieved a net margin of -142.12 while generating a return on equity of -137.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
TransMedics Group Inc.’s EPS decrease for this current 12-month fiscal period is -101.20% and is forecasted to reach -0.70 in the upcoming year.
TransMedics Group Inc. (NASDAQ: TMDX) Trading Performance Indicators
Let’s observe the current performance indicators for TransMedics Group Inc. (TMDX). It’s Quick Ratio in the last reported quarter now stands at 10.40. The Stock has managed to achieve an average true range (ATR) of 2.63. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 33.90.
In the same vein, TMDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.40, a figure that is expected to reach -0.25 in the next quarter, and analysts are predicting that it will be -0.70 at the market close of one year from today.
Technical Analysis of TransMedics Group Inc. (TMDX)
Going through the that latest performance of [TransMedics Group Inc., TMDX]. Its last 5-days volume of 1.57 million indicated improvement to the volume of 0.4 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 65.36% While, its Average True Range was 3.15.
Raw Stochastic average of TransMedics Group Inc. (TMDX) in the period of the previous 100 days is set at 76.23%, which indicates a major rise in contrast to 60.06% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 113.16% that was higher than 69.74% volatility it exhibited in the past 100-days period.